Sponsor: 
Merck Sharp & Dohme (Australia)
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in people aged ≥12 months.

Monovalent hepatitis A vaccine

Adult formulation

Each 1.0 mL monodose vial or pre-filled syringe contains:

  • approximately 50 units of hepatitis A virus protein
  • 0.45 mg aluminium as aluminium hydroxide
  • 70 µg borax

Paediatric/adolescent formulation

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • approximately 25 units of hepatitis A virus protein
  • 0.225 mg aluminium as aluminium hydroxide
  • 35 µg borax

Both formulations contain traces of:

  • formaldehyde
  • neomycin
  • bovine serum albumin
  • latex

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018